InvestorsHub Logo
Followers 56
Posts 8436
Boards Moderated 0
Alias Born 05/14/2015

Re: 29YEARINVESTOR post# 114377

Thursday, 10/13/2022 4:33:25 PM

Thursday, October 13, 2022 4:33:25 PM

Post# of 118384
And how are those patients doing now? Where is the study published?

Oh wait, none of that actually exsits so we are going by what the press release states.

That's not how it works and why nothing ever happened with HemaX 1 or HemaX II.

Again, many have a hard time understanding how therapies get approved in the USA, and to date, Koos has had ZERO success in getting anything into P1 trials as well as having no biotech or pharma of significance show ANY INTEREST IN WHAT REGEN IS DOING.


One can try to spin the facts to make it seem like they don't exist but at the end of the day, this OTC stock is trading at .006 on light volume with, supposedly, only one person buying up millions of shares.

That's a recipe for disaster.

FACTS are stubborn things